A8.15 Enzymatic lipid oxidation by 12/15-lipoxygenase regulates maturation and function of dendritic cells. (31st January 2014)

• Record Type: Journal Article
• Authors: Rothe, Tobias; Oskolkova, Olga; Steinkasserer, Alexander; Bochkov, Valery N; Schett, Georg; Zinser, Elisabeth; Krönke, Gerhard
• Is Part Of: Annals of the rheumatic diseases. Volume 73:Supplement 1(2014)
• Page Start: A82
• Page End: A82
• Publication Date: 2014-01-31
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2013-205124.189
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background and Objectives: Upon the encounter of pathogens, dendritic cells (DCs) undergo a process of maturation, which allows them to initiate and orchestrate T-cell-driven immune responses. To avoid random T-cell activation and autoimmunity, respectively, DC maturation has to be tightly controlled. Here we aimed to elucidate the role of 12/15-lipoxygenase (12/15-LO)-mediated enzymatic lipid oxidation during DC-activation/maturation and the fine-tuning of the consecutive T-cell response. Materials and Methods: To delineate the role of 12/15-LO in DCs, we analysed the phenotype of 12/15 -/- bone marrow-derived DCs and performed the model of experimental autoimmune enzephalomyelitis (EAE) in wild type and 12/15-LO -/- mice. Results: Differentiated bone marrow-derived DCs expressed 12/15-LO and were enriched in 12/15-LO-specific lipid oxidation products. Deletion of this enzyme resulted in enhanced DC maturation and a shift in their cytokine expression profile, which favoured the differentiation of Th17 T-cells. In contrast, both the activation of DCs and the development of Th17 T-cells were attenuated by exposure to 12/15-LO-derived oxidised phospholipids. The analysis of the lymphatic tissues of 12/15-LO-deficient mice confirmed an enhanced maturation of CD11c + CD11b + CD8 - DCs as well as an increased differentiation of Th17 cells that was paralleled by an exacerbation of Th17-driven autoimmune disease. Conclusions: Our data identify 12/15-LO as novel factor modulating the function of DCs and indicate a central, and so far unrecognised, role for enzymatic lipid oxidation during the shaping of the adaptive immune response.